Intracoronary adjunctive therapies for ST-elevation myocardial infarction: a network meta-analysis of trials.
Article 2025 en
Authors
RL
Renzo Laborante
EB
Emiliano Bianchini
GC
Giuseppe Ciliberti
Abstract
1 min read
Adjunctive IC treatments during primary PCI do not influence hard clinical outcomes compared to conventional therapy within a mean 8-month follow-up, although several of them lead to an improvement in surrogate endpoints of CMVO.
Ply Chichareon, Rodrigo Modolo, Carlos Collet, Erhan Tenekecioğlu, M Vink, Pyung Chun Oh, Jung‐Min Ahn, Carmine Musto, Luis S. Díaz de la Llera, Young‐Seok Cho, Roberto Violini, Seung‐Jung Park, Harry Suryapranata, Jan J. Piek, Robbert J. de Winter, Joanna J. Wykrzykowska, Christian Spaulding, Woong Chol Kang, Ton Slagboom, Sjoerd H. Hofma, Inge Wijnbergen, Emilio Di Lorenzo, Nico H.J. Pijls, Lorenz Räber, Salvatore Brugaletta, Manel Sabaté, Hans-Peter Stoll, Gregg W. Stone, Stephan Windecker, Yoshinobu Onuma, Patrick W. Serruys
Henricus J. Duckers, Jaco H. Houtgraaf, Robert‐Jan van Geuns, Bas D van Dalen, Evelien Regar, Wim van der Giessen, Peter de Jaegere, Carl Schultz, Michael Martin, Alexander M. Milstein, F J Fernandez-Aviles, Patrick W. Serruys
Henricus J. Duckers, Jaco H. Houtgraaf, Robert‐Jan van Geuns, Bas D van Dalen, Evelien Regar, Wim van der Giessen, Peter de Jaegere, Carl Schultz, Michael Martin, Alexander M. Milstein, F J Fernandez-Aviles, Patrick W. Serruys
Vasim Farooq, Patrick W. Serruys, Ahmad Mustafa, Mamas A. Mamas, Nadim Malik, Hafez A. Alhous, Magdi El‐Omar, Cara Hendry, D. N. Rana, David Shelton, Paul K. Wright, Nadira Narine, Bernard Clarke, Bernard Keavney, Farzin Fath‐Ordoubadi, Douglas Fraser
Discussion(0)
No comments yet. Be the first to comment.